Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Randomized, Double-Blind, Placebo-Controlled Study of Rosiglitazone for Patients with HIV Lipodystrophy

Randomized, Double-Blind, Placebo-Controlled Study of Rosiglitazone for Patients with HIV Lipodystrophy. 2003.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.